Monotherapy with GI262570, a tyrosine-based non-thiazolidinedione PPARγ agonist, improves metabolic control in Type 2 diabetes mellitus patients

被引：0
|
作者：
Fiedorek, FT
Wilson, GG
Frith, L
Patel, J
Abou-Donia, M
机构：
来源：
DIABETES | 2000年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
157
引用
收藏
页码：A38 / A39
页数：2
相关论文
共 40 条
  • [31] HM11260C, a new generation long acting GLP-1R agonist with a unique pharmacokinetic profile improves glucose control and GI tolerability; a phase IIa clinical trial in type 2 diabetes mellitus
    Kang, J.
    Choi, S.
    Choi, I.
    Kwon, S.
    Trautmann, M.
    Yoon, K.
    Son, J.
    DIABETOLOGIA, 2013, 56 : S401 - S401
  • [32] Improvement of non-invasive tests of liver steatosis and fibrosis as indicators for non-alcoholic fatty liver disease in type 2 diabetes mellitus patients with elevated cardiovascular risk profile using the PPAR-α/γ agonist aleglitazar
    Grobbee, Esmee J.
    de Jong, Vivian D.
    Schrieks, Ilse C.
    Tushuizen, Maarten E.
    Holleboom, Adriaan G.
    Tardif, Jean-Claude
    Lincoff, A. Michael
    Schwartz, Gregory G.
    Cabezas, Manuel Castro
    Grobbee, Diederick E.
    PLOS ONE, 2022, 17 (11):
  • [33] Needle-free jet injection of insulin glargine improves glycemic control in patients with type 2 diabetes mellitus: a study based on the flash glucose monitoring system
    Kong, Xiaocen
    Luo, Menghui
    Cai, Ling
    Zhang, Peng
    Yan, Rengna
    Hu, Yun
    Li, Huiqin
    Ma, Jianhua
    EXPERT OPINION ON DRUG DELIVERY, 2021, 18 (05) : 635 - 641
  • [34] ASSOCIATION OF GLUCAGON-LIKE PEPTIDASE 1 RECEPTOR AGONIST WITH LIVER AND NON-LIVER COMPLICATIONS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
    Nguyen, Mindie
    Mao, Xianhua
    Zhang, Xinrong
    Lai, Rongtao
    Cheung, Ka-Shing
    Yuen, Man-Fung
    Cheung, Ramsey
    Seto, Wai-Kay
    HEPATOLOGY, 2024, 80 : S884 - S884
  • [35] An Okinawan-based Nordic diet improves anthropometry, metabolic control, and health-related quality of life in Scandinavian patients with type 2 diabetes: a pilot trial
    Darwiche, Gassan
    Hoglund, Peter
    Roth, Bodil
    Larsson, Ewa
    Sjoberg, Trygve
    Wohlfart, Bjorn
    Steen, Stig
    Ohlsson, Bodil
    FOOD & NUTRITION RESEARCH, 2016, 60
  • [36] Improvement of non-invasive tests of liver steatosis and fibrosis as indicators for non-alcoholic fatty liver disease in type 2 diabetes mellitus patients with elevated cardiovascular risk profile using the PPAR-alpha/gamma agonist aleglitazar
    Grobbee, Esmee J.
    de Jong, Vivian D.
    Schrieks, Ilse C.
    Tushuizen, Maarten E.
    Holleboom, Adriaan G.
    Tardif, Jean-Claude
    Lincoff, A. Michael
    Schwartz, Gregory G.
    Castro Cabezas, Manuel
    Grobbee, Diederick E.
    PLOS ONE, 2022, 17 (11):
  • [37] Improvement of quality of life and metabolic control of patients with Type-1-and insulin treated Type-2-diabetes mellitus -: results of a population-based 10 years follow up (JEVIN)
    Rillig, A
    Schiel, R
    Braun, A
    Müller, U
    DIABETOLOGIA, 2002, 45 : A313 - A313
  • [38] Using ginger supplement in adjunct with non-surgical periodontal therapy improves metabolic and periodontal parameters in patients with type 2 diabetes mellitus and chronic periodontitis: A double-blind, placebo-controlled trial
    Gholinezhad, Hasan
    Bazyar, Hadi
    Rashidi, Homeira
    Salehi, Parvin
    Haghighi-zadeh, Mohammad Hosein
    Javid, Ahmad Zare
    JOURNAL OF HERBAL MEDICINE, 2020, 20
  • [39] K-111, a novel non-TZD insulin sensitizer improves glycaemic control without oedema or weight gain in treatment-naive patients with type 2 diabetes mellitus (T2DM)
    Schaefer, Silke A.
    Haering, Hans U.
    Yamada, Tadashi
    Giersch, Klaus H.
    DIABETES, 2006, 55 : A114 - A114
  • [40] HABITUAL PHYSICAL-ACTIVITY, AEROBIC CAPACITY AND METABOLIC CONTROL IN PATIENTS WITH NEWLY-DIAGNOSED TYPE-2 (NON-INSULIN-DEPENDENT) DIABETES-MELLITUS - EFFECT OF 1-YEAR DIET AND EXERCISE INTERVENTION
    VANNINEN, E
    UUSITUPA, M
    SIITONEN, O
    LAITINEN, J
    LANSIMIES, E
    DIABETOLOGIA, 1992, 35 (04) : 340 - 346
1234